1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | During that same visit, LPA Moleski observed signatures missing for nighttime doses of three medications listed for the evening of September 20, 2023, and for daytime doses of two medications for the morning of September 20, 2023.
During a visit on October 5, 2023, LPA Moleski observed four of R1’s medication bottles empty. S1 said staff had called to order refills but the pharmacies were running late. One of these medications, a 30-tablet bottle of an antibiotic, was started on September 2, 2023, according to R1’s centrally stored medication records. R1 was to take one tablet daily. According to R1’s MARs, R1 was given a dose of this medication each day from September 2, 2023 through October 3, 2023. Based on the start date recorded in R1’s centrally stored medication records, and based on the doses recorded in R1’s MARs, this medication should have run out on September 31, 2023, not on October 3, 2023.
During the same visit on October 5, 2023, LPA Moleski observed in R1’s centrally stored medication records that R1 started a 30-capsule bottle of medication on September 2, 2023. This medication was not listed on R1’s MARs for the month of September. LPA Moleski reviewed hospital discharge orders for R1 from a hospital visit dated August 21, 2023 to September 1, 2023 which discontinued the medication. On R1’s MARs for October 2023, R1 was given daily doses of the medication from October 1 to October 5, according to the MARs. During the same visit on October 5, 2023, LPA Moleski interviewed a staff member (S1). S1 said R1 was not given doses of the medication from October 1, 2023 through October 3, 2023, and admitted to falsely marking the MARs as if medication had been given, though none was. S1 said there was no new start order for the medication. LPA Moleski interviewed a second staff member (S2). S2 said R1 had been given doses of the discontinued medication on October 4, 2023 and October 5, 2023. During the same visit on October 5, 2023, LPA Moleski observed that only two capsules of the medication remained of the 30-capsule bottle. Based on doses signed off in R1’s MARs, a minimum of 25 capsules should have remained as of October 5, 2023. S1 said S1 flushed an unknown quantity of capsules at an unspecified date. S1 said there were no witnesses to this act. R1’s medication destruction records were blank as of October 5, 2023.
[continued on 9099-C] |